Enzo Biochem Inc (ENZB)

Currency in USD
0.683
-0.004(-0.58%)
Closed·
ENZB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
Fair Value
Day's Range
0.6820.685
52 wk Range
0.2521.129
Key Statistics
Prev. Close
0.686
Open
0.682
Day's Range
0.682-0.685
52 wk Range
0.252-1.129
Volume
33.29K
Average Volume (3m)
363.07K
1-Year Change
-31.94%
Book Value / Share
0.83
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ENZB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Enzo Biochem Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Enzo Biochem Inc Company Profile

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.

Employees
131

Compare ENZB to Peers and Sector

Metrics to compare
ENZB
Peers
Sector
Relationship
P/E Ratio
−4.6x−1.8x−0.5x
PEG Ratio
0.030.040.00
Price/Book
0.8x1.1x2.6x
Price / LTM Sales
1.3x1.6x3.3x
Upside (Analyst Target)
-139.7%45.4%
Fair Value Upside
Unlock19.3%7.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.15%
Dividend Yield
58.61%
Industry Median 2.85%
Annualised payout
0.40
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jun 16, 2025
EPS / Forecast
-0.05 / --
Revenue / Forecast
6.40M / --
EPS Revisions
Last 90 days

ENZB Income Statement

People Also Watch

10.01
DLO
-2.44%
0.159
NCL
-4.80%
6.38
CODI
-0.16%
168.10
CRCL
-8.40%
1.420
BGFV
+0.71%

FAQ

What Stock Exchange Does Enzo Biochem Trade On?

Enzo Biochem is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Enzo Biochem?

The stock symbol for Enzo Biochem is "ENZB."

What Is the Enzo Biochem Market Cap?

As of today, Enzo Biochem market cap is 35.73M.

What Is Enzo Biochem's Earnings Per Share (TTM)?

The Enzo Biochem EPS (TTM) is -0.15.

When Is the Next Enzo Biochem Earnings Date?

Enzo Biochem will release its next earnings report on 20 Oct 2025.

From a Technical Analysis Perspective, Is ENZB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Enzo Biochem Stock Split?

Enzo Biochem has split 11 times.

How Many Employees Does Enzo Biochem Have?

Enzo Biochem has 131 employees.

What is the current trading status of Enzo Biochem (ENZB)?

As of 03 Aug 2025, Enzo Biochem (ENZB) is trading at a price of 0.68, with a previous close of 0.69. The stock has fluctuated within a day range of 0.68 to 0.69, while its 52-week range spans from 0.25 to 1.13.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.